Australia markets closed

Cogstate Limited (CGS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.7750+0.0750 (+4.41%)
At close: 04:10PM AEST

Cogstate Limited

425 Smith Street
Suite 117
Fitzroy, VIC 3065
Australia
61 3 9664 1300
https://www.cogstate.com

Sector(s):Β Healthcare
Industry:Β Health Information Services
Full-time employees:Β 170

Key executives

NameTitlePayExercisedYear born
Mr. Bradley O'Connor C.A., B.Bus, CACEO, MD & Exec. Director949.49kN/AN/A
Prof. Paul Maruff BBSc (Hons), Ph.D.Founder & Chief Innovation Officer566.2kN/AN/A
Mr. Darren WatsonChief Financial Officer371.24kN/AN/A
Mr. Benjamin BloomfieldChief Technology Officer380.83kN/AN/A
Mr. Kenneth BillardChief Commercial Officer592.61kN/AN/A
Dr. Chris Edgar Ph.D.Chief Science OfficerN/AN/AN/A
Ms. Rachel ColiteVP of Strategic Initiatives, Communication & PeopleN/AN/AN/A
Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.Company Sec.N/AN/A1970
Dr. Amy E. Veroff Ph.D.Principal ConsultantN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. As of June 30, 2021, it had participated in approximately 1,800 academic research studies in approximately 200 indications. Cogstate Limited was incorporated in 1999 and is based in Fitzroy, Australia.

Corporate governance

Cogstate Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.